Sorry, you need to enable JavaScript to visit this website.

U.S. Fda Approves DAURISMO™ (glasdegib) for Adult Patients with Newly-diagnosed Acute Myeloid Leukemia (Aml) for Whom Intensive Chemotherapy Is Not an Option

November 26, 2018